# Vasopressin and Epinephrine Versus Epinephrine Alone in Cardiac Arrest

> **NCT00127907** · PHASE4 · COMPLETED · sponsor: **Hospices Civils de Lyon** · enrollment: 2416 (—)

## Conditions studied

- Cardiac Arrest

## Interventions

- **DRUG:** epinephrine (1 mg/1 mL)
- **DRUG:** arginine-vasopressin (40 UI/2 mL)

## Key facts

- **NCT ID:** NCT00127907
- **Lead sponsor:** Hospices Civils de Lyon
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-05
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 2416 (—)
- **Last updated:** 2007-10-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00127907

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00127907, "Vasopressin and Epinephrine Versus Epinephrine Alone in Cardiac Arrest". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT00127907. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*